These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 16876514

  • 21. Preliminary results of primary chemotherapy in retinoblastoma.
    Bornfeld N, Schüler A, Bechrakis N, Henze G, Havers W.
    Klin Padiatr; 1997; 209(4):216-21. PubMed ID: 9293453
    [Abstract] [Full Text] [Related]

  • 22. Severe aseptic orbital cellulitis with subtenon carboplatin for intraocular retinoblastoma.
    Shah PK, Kalpana N, Narendran V, Ramakrishnan M.
    Indian J Ophthalmol; 2011; 59(1):49-51. PubMed ID: 21157073
    [Abstract] [Full Text] [Related]

  • 23. [Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
    Balwierz W, Pietrys D, Romanowska-Dixon B, Kobylarz J, Pawińska-Wasikowska K, Moryl-Bujakowska A.
    Przegl Lek; 2010; 67(6):404-8. PubMed ID: 21344770
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP.
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [Abstract] [Full Text] [Related]

  • 27. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
    Qian J, Xue K, Gao YJ, Yuan YF, Shan HD, Bi YW.
    Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
    [Abstract] [Full Text] [Related]

  • 28. Ophthalmic vasculature alterations following systemic chemotherapy and periocular Carboplatin treatment of advanced retinoblastoma.
    Piña Y, Boutrid H, Murray TG, Wolfe SQ, Schefler AC, Houston SK, Moftakhar R, Fernandes CE, Reichbach J, Aziz HA, Markoe AM, Aziz-Sultan MA.
    J Pediatr Ophthalmol Strabismus; 2010 Sep 22; 47 Online():e1-5. PubMed ID: 20886809
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track.
    Munier FL, Soliman S, Moulin AP, Gaillard MC, Balmer A, Beck-Popovic M.
    Br J Ophthalmol; 2012 Aug 22; 96(8):1084-7. PubMed ID: 22368262
    [Abstract] [Full Text] [Related]

  • 31. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2009 Mar 22; 116(3):544-551.e1. PubMed ID: 19157557
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
    Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA.
    J Neurosurg; 2011 Jun 22; 114(6):1603-8. PubMed ID: 21294621
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
    Aerts I, Sastre-Garau X, Savignoni A, Lumbroso-Le Rouic L, Thebaud-Leculée E, Frappaz D, Coze C, Thomas C, Gauthier-Villars M, Lévy-Gabriel C, Brisse HJ, Desjardins L, Doz F.
    J Clin Oncol; 2013 Apr 10; 31(11):1458-63. PubMed ID: 23460706
    [Abstract] [Full Text] [Related]

  • 37. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH.
    Pediatr Blood Cancer; 2007 Sep 10; 49(3):256-60. PubMed ID: 17029248
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
    Brennan RC, Qaddoumi I, Billups CA, Free TL, Haik BG, Rodriguez-Galindo C, Wilson MW.
    Br J Ophthalmol; 2015 Oct 10; 99(10):1366-71. PubMed ID: 25873648
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.